Health Minister Rushikesh Patel launches Genexplore Diagnostics’ advanced genetic lab

Ahmedabad (Gujarat) : A major step forward in the area of genetic diagnostics was taken with the opening of the cutting-edge advanced laboratory at Genexplore Diagnostics & Research Centre in Ahmedabad, India.

Ten years of delivering essential genetic services is cause for celebration at Genexplore Diagnostics & Research Centre. The new facility, which is conveniently located at the Shyamal intersection, is going to completely change the face of genetic testing and study in the city.

The event’s keynote speaker was Health Minister Rushikesh Patel. Hasmukh Patel, Member of Parliament for Ahmedabad East; Pratibha Jain, Mayor of Ahmedabad; Dr. Hasmukh Patel, MLA; Amit Shah, MLA; Babusinh Yadav, MLA; Dinesh Kushwah, MLA; and other dignitaries.

“Every year, thousands of children are born in India with various congenital malformations and genetic disorders, such as G6PD deficiency, Down syndrome, beta-thalassemia, sickle cell anaemia, and amino acid disorders,” Health Minister Rushikesh Patel said in his speech. In order to test for and provide early identification and diagnosis of genetic abnormalities, the state of Gujarat has established an outpatient department at Ahmedabad Civil Hospital. This new laboratory has state-of-the-art equipment that will aid in our quest for earlier diagnosis, more effective treatment, and better patient outcomes.

The center’s directors, Drs. Alpesh Patel and Shiva Shankaran Chettiar, also work at the Indian Red Cross and B J Medical College to provide genetic counselling to the public. On Tuesdays and Fridays, the B J Medical campus has an open door policy (OPD) for the general public and low-income patients, overseen by the honourable health minister.

“The opening of our advanced laboratory is a significant step forward in the field of genetic diagnostics and will enhance our ability to diagnose a wide range of genetic conditions,” said Genexplore Diagnostics and Research Centre directors Drs. Alpesh Patel and Shiva Shankaran Chettiar. Improved healthcare and better quality of life for people with genetic illnesses will be made possible in large part by advances in genetic diagnosis. Rapid increases in rates of infertility, cancer, and other lifestyle-related illnesses highlight the need of early and accurate diagnosis. The clinical decision-making process can only be aided by molecular diagnostics. After the devastating CoVD19 pandemic, genetic testing gained widespread acceptance and became indispensable.

The new lab offers a wide variety of clinical services and cutting-edge technology. The laboratory is equipped for a variety of tests, including karyotyping, FISH, PCR, RT-PCR, Sanger sequencing, microarrays, and NGS. The facility’s cutting-edge equipment allows doctors to provide accurate diagnoses to those suffering from infertility, cancer, and neurological disorders.

Cytogenetic services, such as karyotyping, fluorescence in situ hybridization, and chromosomal microarray; Molecular Diagnosis services for identifying single gene disorders and infectious diseases; and Advanced Genomic Services, including microarray analysis and next-generation sequencing, are all available to patients at the lab. The facility’s cutting-edge equipment allows doctors to provide accurate diagnoses to those suffering from infertility, cancer, and neurological disorders.

In addition to genomic services like Sanger sequencing, microarray analysis, and next-generation sequencing, Genexplore’s cutting-edge laboratory will provide a wide range of in vitro and in vivo assays, including cell line-based assays, anticancer assays, and biocompatibility assays.

Individuals with some uncommon genetic illnesses have variations in their DNA that put them at risk for experiencing recurrent miscarriages, congenital abnormalities, cancer, infertility, neurological issues, and muscle limitations. GeneXplore Diagnostic and Research Centre is where these mutations may be explored in depth. In order to improve the success rate of in vitro fertilisation (IVF), this facility performs single cell studies on just a few embryo cells to determine which embryo is best suited for implantation.

It is estimated that 4.95 lakh infants are born each year with some sort of congenital defect. G6PD deficiency affects over 3.9 lakh, Down syndrome about 21,400, beta thalassemia about 9,000, sickle cell anaemia about 5,200, and amino acid abnormalities about 9,760.

Healthcare providers and members of the general public are encouraged to learn more about the services provided by Genexplore Diagnostics & Research Centre.